Cidara Therapeutics, Inc. (CDTX)

NASDAQ: CDTX · IEX Real-Time Price · USD

0.681

-0.041 (-5.68%)

At close: Apr 19, 2024, 4:00 PM

0.682

+0.001 (0.15%)

After-hours: Apr 19, 2024, 7:36 PM EDT

Cidara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-29.8	-42.47	-74.87	-41.09	-69.35	-55.73	-48.17	-32.19	-11.89	-1.34
Depreciation & Amortization	0.14	0.19	0.29	0.33	0.52	0.67	0.73	0.46	0.18	0
Share-Based Compensation	3.53	4.01	4.09	5.07	5.71	5.71	4.34	3.03	0.23	0.01
Other Operating Activities	-2.35	13.03	13.32	7.16	-3.92	-0.56	3.32	2.74	3.77	0.29
Operating Cash Flow	-28.47	-25.23	-54.41	-28.53	-56.71	-49.91	-39.77	-25.96	-7.71	-1.05
Capital Expenditures	-0.12	-0.04	-0.19	-0.04	-0.18	-0.31	-0.4	-1.17	-0.99	0
Change in Investments	0	0	0	0	14.48	4.78	25.88	-44.92	0	0
Investing Cash Flow	-0.12	-0.04	-0.19	-0.04	14.3	4.47	25.48	-46.09	-0.99	0
Share Issuance / Repurchase	1.64	49.04	40.24	14.3	56.15	20.88	27.15	69.89	0.75	0
Debt Issued / Paid	-2.59	-4.44	-2.96	0	0	0	9.95	0	0	0
Other Financing Activities	-	-	-	-0.03	-	-	-	41.92	30.56	1.23
Financing Cash Flow	-0.95	44.6	37.28	14.27	56.15	20.88	37.09	111.81	31.31	1.23
Net Cash Flow	-29.54	19.32	-17.32	-14.29	13.75	-24.55	22.81	39.77	22.61	0.18
Free Cash Flow	-28.59	-25.27	-54.6	-28.57	-56.88	-50.22	-40.17	-27.13	-8.7	-1.05
Free Cash Flow Margin	-44.47%	-50.98%	-452.45%	-136.59%	-	-	-	-	-	-
Free Cash Flow Per Share	-0.41	-0.48	-1.31	-0.95	-2.20	-2.87	-2.77	-2.73	-10.61	-3.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).